ID   BREF7_EUPBR             Reviewed;        2373 AA.
AC   A0A068ABB7;
DT   18-JUL-2018, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2014, sequence version 1.
DT   07-APR-2021, entry version 33.
DE   RecName: Full=Highly reducing polyketide synthase {ECO:0000303|PubMed:24845309};
DE            Short=HRPKS {ECO:0000303|PubMed:24845309};
DE            EC=2.3.1.- {ECO:0000269|PubMed:24845309};
DE   AltName: Full=Brefeldin A biosynthesis cluster protein {ECO:0000303|PubMed:24845309};
GN   Name=Bref-PKS {ECO:0000303|PubMed:24845309};
GN   Synonyms=orf7 {ECO:0000303|PubMed:24845309};
OS   Eupenicillium brefeldianum (Penicillium brefeldianum).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Penicillium.
OX   NCBI_TaxID=1131482;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], INDUCTION, FUNCTION, CATALYTIC ACTIVITY,
RP   DOMAIN, AND PATHWAY.
RC   STRAIN=ATCC 58665;
RX   PubMed=24845309; DOI=10.1021/cb500284t;
RA   Zabala A.O., Chooi Y.H., Choi M.S., Lin H.C., Tang Y.;
RT   "Fungal polyketide synthase product chain-length control by partnering
RT   thiohydrolase.";
RL   ACS Chem. Biol. 9:1576-1586(2014).
CC   -!- FUNCTION: Highly reducing polyketide synthase; part of the gene cluster
CC       that mediates the biosynthesis of brefeldin A (BFA), a protein
CC       transport inhibitor that shows antiviral, antifungal, and antitumor
CC       properties (PubMed:24845309). The proposed biosynthesis of BFA involves
CC       formation of an acyclic polyketide chain that is differentially
CC       tailored throughout the backbone (PubMed:24845309). The highly reducing
CC       polyketide synthase Bref-PKS is proposed to synthesize the precisely
CC       reduced octaketide precursor, which could then be directly offloaded by
CC       the thiohydrolase enzyme Bref-TH followed by a cytochrome P450
CC       monooxygenase-mediated formation of the cyclopentane ring and
CC       macrocyclization to afford 7-deoxy BFA. Alternatively, the first ring
CC       annulation can also occur on the ACP-tethered intermediate before the
CC       thiohydrolase release and lactonization (PubMed:24845309). The C7-
CC       hydroxylation by another cytochrome P450 monooxygenase is believed to
CC       be the final step in the process to obtain the final structure of BFA
CC       (PubMed:24845309). In addition to the HRPKS Bref-PKS and the
CC       thiohydrolase Bref-TH, the brefeldin A biosynthesis cluster contains 4
CC       cytochrome p450 monooxygenases (called orf3 to orf6), as well a the
CC       probable cluster-specific transcription regulator orf8
CC       (PubMed:24845309). {ECO:0000269|PubMed:24845309}.
CC   -!- COFACTOR:
CC       Name=pantetheine 4'-phosphate; Xref=ChEBI:CHEBI:47942;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y8A5};
CC       Note=Binds 1 phosphopantetheine covalently.
CC       {ECO:0000250|UniProtKB:Q9Y8A5};
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:24845309}.
CC   -!- INDUCTION: Coexpressed with the other cluster genes on brefeldin A
CC       production optimized medium. {ECO:0000269|PubMed:24845309}.
CC   -!- DOMAIN: Multidomain protein; including a ketosynthase (KS) that
CC       catalyzes repeated decarboxylative condensation to elongate the
CC       polyketide backbone; a malonyl-CoA:ACP transacylase (MAT) that selects
CC       and transfers the extender unit malonyl-CoA; a dehydratase (DH) domain
CC       that reduces hydroxyl groups to enoyl groups; an enoylreductase (ER)
CC       domain that reduces enoyl groups to alkyl group; a ketoreductase (KR)
CC       domain that catalyzes beta-ketoreduction steps; and an acyl-carrier
CC       protein (ACP) that serves as the tether of the growing and completed
CC       polyketide via its phosphopantetheinyl arm.
CC       {ECO:0000305|PubMed:24845309}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KJ728786; AIA58899.1; -; Genomic_DNA.
DR   SMR; A0A068ABB7; -.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW.
DR   GO; GO:0008152; P:metabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.10.129.110; -; 1.
DR   Gene3D; 3.40.366.10; -; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   InterPro; IPR001227; Ac_transferase_dom_sf.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR013154; ADH_N.
DR   InterPro; IPR011032; GroES-like_sf.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR032821; PKS_assoc.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR020807; PKS_dehydratase.
DR   InterPro; IPR042104; PKS_dehydratase_sf.
DR   InterPro; IPR020843; PKS_ER.
DR   InterPro; IPR013968; PKS_KR.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR016039; Thiolase-like.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF08240; ADH_N; 1.
DR   Pfam; PF16197; KAsynt_C_assoc; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   Pfam; PF08659; KR; 1.
DR   Pfam; PF14765; PS-DH; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00826; PKS_DH; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 1.
DR   SUPFAM; SSF47336; SSF47336; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   SUPFAM; SSF51735; SSF51735; 3.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   SUPFAM; SSF53901; SSF53901; 1.
DR   SUPFAM; SSF55048; SSF55048; 1.
DR   PROSITE; PS50075; CARRIER; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Multifunctional enzyme; NADP; Oxidoreductase;
KW   Phosphopantetheine; Phosphoprotein; Transferase.
FT   CHAIN           1..2373
FT                   /note="Highly reducing polyketide synthase"
FT                   /id="PRO_0000444935"
FT   DOMAIN          2294..2370
FT                   /note="Carrier"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258,
FT                   ECO:0000305|PubMed:24845309"
FT   REGION          22..449
FT                   /note="Ketosynthase (KS) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:24845309"
FT   REGION          560..874
FT                   /note="Malonyl-CoA:ACP transacylase (MAT) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:24845309"
FT   REGION          942..1241
FT                   /note="Dehydrogenase (DH) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:24845309"
FT   REGION          1669..1985
FT                   /note="Enoyl reductase (ER) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:24845309"
FT   REGION          2010..2187
FT                   /note="Ketoreductase (KR) domain"
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:24845309"
FT   ACT_SITE        192
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        192
FT                   /note="For beta-ketoacyl synthase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        652
FT                   /note="For malonyltransferase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        974
FT                   /note="For beta-hydroxyacyl dehydratase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   MOD_RES         2330
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ   SEQUENCE   2373 AA;  257334 MW;  0E684BC86CF00D14 CRC64;
     MAPHNSLDDT PLSSRTFIQE PIAVVGIACR LPGHSSTPKK LWDFLERGGI AANDTPSTRF
     NLAAHHDGSK KPKTMRTPGG MFIEDADPRD FDAGFFGISG ADAAAMDPQQ RQLMEVVYEC
     LENSGVPFEK LYGAQVACHV GSYAVDYDAI QARDPEDRAP GAVVGIGRAM LSNRISHFFN
     FKGPSMTIDT ACSGSLVGLD VACRYLHTGE VDGAIIGGAN MYFSPEHNLN TGAMSVANSL
     SGRCHTFDVK ADGYCKAEAI NCVYLKRLSD AVRDGDPIRA VIRGSATNSD GNTPGIASPN
     SAAQAAAIRS AYANAGITNL NDTSYLEFHG TGTQAGDPLE AGGVASVFSA SRKPEAPLYI
     GSVKSNIGHS EPAAGISGLI KAILSIEKDL IPGNPTFITP TPKIDFEGLK LQPSRANRRW
     PAAPFKRASV NSFGYGGSNA HVIVEEPKVL LPDMESTYVS SYQTEADLFA DDEEVAGGRL
     QLLVLSANDE ASLRANATTL KNYLTNPNVK ISLGDLSHTL SERRSHHFHR GYLITDKASI
     DENALVIGKK STNEPRVGFI FTGQGAQWPQ MGKAIIDTFP EARAVVLELD EFLQSSSLPP
     SWSLLGELTE PREAEHLRKP EFSQPLVTAL QIALFDILQR WGISPRAVAG HSSGEIAAAY
     AAGLLSKKAA IRAAYYRGQA AALAEKGTAD QNQQAFGMMA TGIGAEGITP YLQGLGQSVQ
     IACYNSPSSL TLSGTVDALA KVQKQLSEDS IFARMLQVNL AYHSTFMREI SQGYTDLLNK
     DFEHLPFKQD SVRMFSSVTG EQLAGPTDSE YWKSNMVCPV RFDAALSNML TASDAPDFLI
     ELGPAGALKG PISQVLKSLE GTKAQYTSAM ARGAADMQSI FAVAGSLYVA GGKVDLAQVN
     KVDGIKPKVV IDLPNYSWNH STKYWYESES SKDWRNRLFP PHDLLGSKVL GSPWRSPAFM
     RSLNVQDLPW IADHKMGPDT VFPATGYISM AMEAIYQRSE ALHMLEGEKK VENPRYRLRD
     VQFKKALVLP DNQSTRMSLT LSAYTGVGDW FEFKVSSLAG TTWIEHVRGL IRIDEDVPQV
     ASAEEIKPLS HQVDASLWHK CMLDAGYSFG PKFLKQLQIE ARPGSRRSRS ILGLEVPESK
     YPQSKYPMHP AAMDGCFQTC APSLWKGNRH AVNAVLVPAM IDSLTITSSK ADRGLSLTSA
     AYVGLGRPTD NKNYMSNASV YDPETGNLLL RLSGLRYTRI DTGPSVYDAH TFSALISKPD
     VSLLSSQSLE NLAEREQGLN DRSFGVATEL VRLAAHKKPA QRVLELNFVP GLSQSIWASA
     IEGQDNIGKT YRQFVYRLTD PKALVEAGQQ YTSEKMEISL LDPEGMTLAE DEFDLVVVRL
     SPAADNVEHV ATQLKKVVKE GGQVLFIRQR SVQNSEVIVN GEAEQFDNGS YADLLKSAGL
     TFAGHVAFEE GNEFASLSLC RVQPEPDCTG KDVAIYHFVE PSTSALKVIT ALKARGWNVT
     TYRAEEASTS PKRFLVLDEL DTALLPTLSP AHWDSLKILL SLDKRVLWVT NGSQTVISEP
     NKAMIHGLGR TVRAEDPLVQ LTTLDVSASS TDATVDSVEV ILERLALPEV FHHVESEFIE
     RNGLLHINRI QPDDQVNAVA SDSYEGSEPV EQSLHDSPNM IRLRCERVGT TDSLIYSEVS
     PYELPLDDNK VEVEVYAAGL NYKDVVITMG IVPENEHILG LEGAGIVRRL GKNVHKVRKL
     DIGQRVLVFK KGAFANRVHA EAERVYPIQD SMTFEETCTL ASSYLTGIHS LFNLADTKAG
     SKVLIHSASG GLGLACIQLC QYVGAEVFAT CGNKEKRDFL VKHAGIPADH IFNSRDTSFG
     AAIMAATNGY GVDTILNSLT GDLLDESWRC IAAEGTMVEL GKRDMLDRKG LSMEPFGRNA
     SYRCFDMGHD IVSDAMINNL LKRLFALLEA GHVKPVHVAT TFGWDNVSGA MRYMRSANHI
     GKIVISSGDK PIIVPVRPSR APLQLRGEAG YLLIGGLKGL CGSVAVNLAS LGAKHIVVMA
     RSGYDDEVSQ RVITDLAALG CTITLGQGDV SKADDVRRVI KQSPVPIGGV IQGAMVLRDR
     VFTDMSIEEY HAAVDCKVAG TWNIHNALIE ENMKVEFFTM LSSVSGVVGQ KGQANYAAAN
     AFLDAFAIYR HNLGLAGNSV DLGAIQDVGY MSHHVDLLEN LSSDAWTPIN EALMLKIVEF
     SLKQQLTPIS KASAGQLITS IAVPQRENSS LLRDARFSTL SFSDGEDVGA GSDGKDAGIQ
     ALQLLVKNKA AVSAIHDAVI DVTVRQFTTM LSLSEPMEPA KAPSSYGLDS LAAVEFRNWV
     RLELKAEVTT LDIISATSLE QLAQKIVARL TAV
//
